Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Jim Cramer says investors should remember the optionality of 6 of the Magnificent 7
CNBC’s Jim Cramer keyed in on the optionality of six of the companies that have become known as the “Magnificent Seven” during his Wednesday show. “The Magnificent Seven have the most optionality of any publicly traded companies in modern history,” Cramer said. “To sell any of them is to forget that they have this kind…
Retailers should build up inventories amid Red Sea tensions, says UST’s Jonathan Colehower
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jonathan Colehower, managing director of global operations and supply chain practice at UST, joins ‘The Exchange’ to discuss tensions at the Red Sea, cargo costs, and more.
Boeing CEO Dave Calhoun calls the Alaska Airlines incident a ‘mistake’ that should never happen
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Boeing CEO Dave Calhoun joins ‘The Exchange’ to discuss the Alaska Airlines incident, how the company is addressing this, and more. 04:00 Wed, Jan 10 20241:22 PM EST
Coinbase CEO Brian Armstrong on SEC ETF decision: We’ll see new pools of capital come into bitcoin
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Coinbase CEO Brian Armstrong joins ‘Squawk Box’ to discuss the SEC’s approval of bitcoin ETFs, what it means for the investing community, what’s next for crypto, and more. 08:32 Thu, Jan 11 20248:45 AM EST
The number one thing we’re concerned about is summer traffic demand, says Cowen’s airline analyst
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Helane Becker, Cowen, joins ‘Squawk on the Street’ to discuss what Delta’s earnings results say about the airline industry, what she’s watching and headwinds for the industry. 03:43 Mon, Apr 18 202211:40 AM EDT
Trader bets gold about to get its shine back
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bullion bounces back. Can gold shine again? With CNBC’s Seema Mody and the Futures Now traders, Jim Iuorio at the CME and Anthony Grisanti at the NYMEX. 02:08 Thu, Sep 26 20192:27 PM EDT
